SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001558370-22-017784
Filing Date
2022-11-14
Accepted
2022-11-14 16:27:54
Documents
75
Period of Report
2022-09-30

Document Format Files

Seq Description Document Type Size
1 10-Q nhwk-20220930x10q.htm   iXBRL 10-Q 1840763
2 EX-31.1 nhwk-20220930xex31d1.htm EX-31.1 26402
3 EX-31.2 nhwk-20220930xex31d2.htm EX-31.2 25785
4 EX-32.1 nhwk-20220930xex32d1.htm EX-32.1 8814
5 EX-32.2 nhwk-20220930xex32d2.htm EX-32.2 8785
  Complete submission text file 0001558370-22-017784.txt   8799844

Data Files

Seq Description Document Type Size
6 EX-101.SCH nhwk-20220930.xsd EX-101.SCH 62441
7 EX-101.CAL nhwk-20220930_cal.xml EX-101.CAL 97009
8 EX-101.DEF nhwk-20220930_def.xml EX-101.DEF 260159
9 EX-101.LAB nhwk-20220930_lab.xml EX-101.LAB 607886
10 EX-101.PRE nhwk-20220930_pre.xml EX-101.PRE 456493
69 EXTRACTED XBRL INSTANCE DOCUMENT nhwk-20220930x10q_htm.xml XML 1540413
Mailing Address 627 DAVIS DRIVE SUITE 400 MORRISVILLE NC 27560
Business Address 627 DAVIS DRIVE SUITE 400 MORRISVILLE NC 27560 919-240-7133
NightHawk Biosciences, Inc. (Filer) CIK: 0001476963 (see all company filings)

IRS No.: 262844103 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-35994 | Film No.: 221386240
SIC: 2834 Pharmaceutical Preparations